MYC and breast cancer: In breast cancer, FGF18 promotes cell proliferation through the ERK/c-Myc signaling pathway and stimulates the production of epithelial-to-mesenchymal transition (EMT) factors, thus, promoting neoplastic cell migration and invasion [47].